Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-05-14 9:10 pm Sale | 13D | iTeos Therapeutics Inc. ITOS | RA CAPITAL MANAGEMENT L.P. | 3,659,046 9.99% | -758,213 (-17.16%) | View |
| 2024-05-10 5:52 pm Purchase | 13G | Medicenna Therapeutics Corp. MDNAF | RA CAPITAL MANAGEMENT L.P. | 7,714,760 9.99% | 7,714,760 (New Position) | View |
| 2024-05-09 8:48 pm Purchase | 13D | Black Diamond Therapeutics Inc. BDTX | RA CAPITAL MANAGEMENT L.P. | 2,788,028 4.95% | 198,124 (+7.65%) | View |
| 2024-05-07 4:52 pm Purchase | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 6,192,881 14.2% | 13,846 (+0.22%) | View |
| 2024-05-06 5:57 pm Purchase | 13G | Avidity Biosciences Inc. RNA | RA CAPITAL MANAGEMENT L.P. | 4,895,959 5.1% | 2,441,426 (+99.47%) | View |
| 2024-05-02 5:58 pm Purchase | 13G | Zura Bio Ltd ZURA | RA CAPITAL MANAGEMENT L.P. | 3,217,503 5.1% | 3,217,503 (New Position) | View |
| 2024-04-30 4:16 pm Purchase | 13D | Aerovate Therapeutics Inc. AVTE | RA CAPITAL MANAGEMENT L.P. | 8,313,982 28.9% | 20,834 (+0.25%) | View |
| 2024-04-25 8:43 pm Purchase | 13G | Protara Therapeutics Inc. TARA | RA CAPITAL MANAGEMENT L.P. | 2,073,075 9.99% | 2,073,075 (New Position) | View |
| 2024-04-15 4:45 pm Purchase | 13G | Surrozen Inc. SRZN | RA CAPITAL MANAGEMENT L.P. | 323,662 9.99% | 323,662 (New Position) | View |
| 2024-04-12 6:52 pm Purchase | 13D | Eliem Therapeutics Inc. ELYM | RA CAPITAL MANAGEMENT L.P. | 13,189,736 47.5% | 10,555 (+0.08%) | View |
| 2024-04-12 4:24 pm Purchase | 13G | BOUNDLESS BIO, INC. BOLD | RA CAPITAL MANAGEMENT L.P. | 2,180,631 9.8% | 2,180,631 (New Position) | View |
| 2024-04-11 7:55 pm Purchase | 13G | CERVOMED INC CRVO | RA CAPITAL MANAGEMENT L.P. | 825,373 9.99% | 825,373 (New Position) | View |
| 2024-04-11 4:16 pm Purchase | 13D | Acrivon Therapeutics Inc. ACRV | RA CAPITAL MANAGEMENT L.P. | 8,359,102 27.1% | 3,541,743 (+73.52%) | View |
| 2024-04-04 7:04 pm Purchase | 13G | DYNE THERAPEUTICS INC DYN | RA CAPITAL MANAGEMENT L.P. | 5,213,661 6.4% | 5,213,661 (New Position) | View |
| 2024-04-01 7:33 pm Purchase | 13G | SERA PROGNOSTICS INC. SERA | RA CAPITAL MANAGEMENT L.P. | 2,047,221 6.5% | 2,047,221 (New Position) | View |
| 2024-03-29 5:41 pm Purchase | 13D | NKARTA INC NKTX | RA CAPITAL MANAGEMENT L.P. | 13,848,371 18.9% | 6,016,031 (+76.81%) | View |
| 2024-03-29 4:14 pm Purchase | 13D | ARS Pharmaceuticals Inc. SPRY | RA CAPITAL MANAGEMENT L.P. | 10,860,977 11.3% | 1,401,299 (+14.81%) | View |
| 2024-03-29 12:54 pm Purchase | 13G | ALTO NEUROSCIENCE INC ANRO | RA CAPITAL MANAGEMENT L.P. | 1,385,491 5.2% | 1,385,491 (New Position) | View |
| 2024-03-28 4:16 pm Purchase | 13D | LENZ Therapeutics Inc. LENZ | RA CAPITAL MANAGEMENT L.P. | 4,250,856 16.6% | 4,250,856 (New Position) | View |
| 2024-03-25 4:18 pm Purchase | 13G | REGULUS THERAPEUTICS INC P RGLS | RA CAPITAL MANAGEMENT L.P. | 6,250,000 9.5% | 6,250,000 (New Position) | View |